跳转至内容
Merck
  • Changes in expression of signal transduction proteins in T lymphocytes of patients with leprosy.

Changes in expression of signal transduction proteins in T lymphocytes of patients with leprosy.

Infection and immunity (1998-02-07)
A H Zea, M T Ochoa, P Ghosh, D L Longo, W G Alvord, L Valderrama, R Falabella, L K Harvey, N Saravia, L H Moreno, A C Ochoa
摘要

Advanced stages of mycobacterial diseases such as leprosy and tuberculosis are characterized by a loss of T-cell function. The basis of this T-cell dysfunction is not well understood. The present report demonstrates major alterations in the expression of signal transduction molecules in T cells of leprosy patients. These alterations were most frequently observed in lepromatous leprosy (LL) patients. Of 29 LL patients, 69% had decreased T-cell receptor zeta-chain expression, 48% had decreased p56(lck) tyrosine kinase, and 63% had a loss of nuclear transcription factor NF-kappaB p65. An electrophoretic mobility shift assay with the gamma interferon core promoter region revealed a loss of the Th1 DNA-binding pattern in LL patients. In contrast, tuberculoid leprosy patients had only minor signal transduction alterations. These novel findings might improve our understanding of the T-cell dysfunction observed in leprosy and other infectious diseases and consequently might lead to better immunologic evaluation of patients.